Regulation of TCR signaling by a novel enzyme activity.

通过新型酶活性调节 TCR 信号传导。

• 批准号: 7297150
• 负责人: NICHOLAS A CARPINO
• 金额: $ 19.38万
• 依托单位: STATE UNIVERSITY NEW YORK STONY BROOK
• 依托单位国家: 美国
• 财政年份: 2007
• 资助国家: 美国
• 起止时间: 2007-09-20 至 2009-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7297150
• 关键词: Antigens; Applications Grants; Area; Autoimmune Diseases; Autoimmunity; Biochemical; Biochemistry; CCL4 gene; Cells; Cues; Data; Defect; Disruption; Employee Strikes; Engineering; Ensure; Enzymes; Etiology; Genes; Goals; Heart; Immune System Diseases; Immune response; Immune system; Laboratories; Light; Link; Modeling; Mouse Strains; Multiple Sclerosis; Mus; Outcome; Pathology; Peripheral; Phenotype; Phosphoric Monoester Hydrolases; Phosphorylation; Play; Predisposition; Production; Proliferating; Property; Proteins; Protocols documentation; Range; Receptor Signaling; Regulation; Research; Research Project Grants; Role; Shapes; Signal Pathway; Signal Transduction; Stream; T-Cell Activation; T-Cell Receptor; T-Lymphocyte; Testing; Translating; Upper arm; ZAP-70 Gene; cytokine; design; enzyme activity; mouse model; mutant; novel; pathogen; prevent; programs; receptor; research study; response

DESCRIPTION (provided by applicant): The T cell auto-reactivity that lies at the heart of many autoimmune diseases arises from the very properties that allow T cells to mount an effective immune response. Thus, to understand the etiology of different autoimmune diseases will require a thorough and integrated understanding of the mechanisms that control T cell activation. The long-term objective of my research is to understand the biochemistry of T cell reactivity. Currently, my laboratory is studying how two related proteins, Sts-1 and Sts-2, act in concert to negatively regulate T cell signaling pathways. The role of Sts-1 and -2 in controlling TCR signaling pathways was revealed by a strain of mice engineered to lack the Sts genes. T cells from Sts- 1/2-/- mice dramatically hyper-proliferate in response to TCR stimulation. This hyper-proliferative phenotype is accompanied by increased activation of signaling pathways downstream of the TCR, elevated levels of cytokine production, and increased susceptibility of Sts-1/2-/- mice to autoimmunity in a mouse model of multiple sclerosis. In our ongoing effort to characterize the functions of the Sts proteins, we recently discovered that Sts-1 has a novel and potent enzyme activity. This activity derives from an evolutionarily conserved region within the protein and our recent data indicates that it plays an essential role in the ability of Sts-1 to regulate TCR signaling pathways. Sts-1 is sufficiently dissimilar to other known enzymes to make it a novel and unique phosphatase. In addition, the connection between Sts-1 catalytic activity and regulation of T cell activation in unknown and unexplored. The experiments outlined in this proposal are designed to shed light on these areas. Our Specific Aims are: 1. To determine the structural features that define and regulate Sts-1 catalytic activity. 2. To determine the role of Sts-1 phosphatase activity in regulating Zap-70 signaling. We will use some recently developed protocols to accomplish our goals. Completion of the studies described herein will help us build a model of how Sts-1 cooperates with Sts-2 and other intracellular signaling mechanisms to control T cell reactivity. It is our hope that a broad, integrated understanding of all the mechanisms that control T cell activation will translate into therapies that prevent the onset of a variety of autoimmune diseases. Autoimmune diseases arise when normal regulatory mechanisms within the immune system fail. Developing therapies that will prevent or cure autoimmune diseases will require a thorough and integrated understanding of the mechanisms that control the immune response. This project focuses on understanding the function of a novel protein that participates in the regulation of T cell activation.

描述(由申请人提供)：T细胞自身反应性是许多自身免疫性疾病的核心，它源于允许T细胞进行有效免疫反应的特性。因此，要了解不同自身免疫性疾病的病因，需要对控制T细胞激活的机制有一个全面而完整的了解。我研究的长期目标是了解T细胞反应性的生物化学。目前，我的实验室正在研究两种相关蛋白质Sts-1和Sts-2如何协同作用，负向调节T细胞信号通路。Sts-1和Sts-2在控制TCR信号通路中的作用，是通过对缺乏Sts基因的小鼠进行改造而揭示的。来自Sts-1/2-/-小鼠的T细胞在TCR刺激下显著过度增殖。在多发性硬化症的小鼠模型中，伴随这种高增殖表型的是TCR下游信号通路的激活增加，细胞因子产生水平的提高，以及Sts-1/2-/-小鼠对自身免疫的易感性增加。在我们正在进行的对Sts蛋白功能的研究中，我们最近发现Sts-1具有一种新的和强大的酶活性。这种活性来源于蛋白质中进化上保守的区域，我们最近的数据表明，它在Sts-1调节TCR信号通路的能力中发挥着重要作用。STS-1与其他已知的酶有很大的不同，使其成为一种新的和独特的磷酸酶。此外，Sts-1催化活性与调节T细胞活化之间的关系尚不清楚和未被探索。这项提案中概述的实验旨在阐明这些领域。我们的具体目标是：1.确定定义和调节Sts-1催化活性的结构特征。2.确定Sts-1磷酸酶活性在调控ZAP-70信号转导中的作用。我们将使用一些最新开发的协议来实现我们的目标。本文描述的研究的完成将帮助我们建立Sts-1如何与Sts-2以及其他细胞内信号机制合作来控制T细胞反应性的模型。我们希望，对控制T细胞激活的所有机制的广泛、完整的理解将转化为预防各种自身免疫性疾病的治疗。当免疫系统内的正常调节机制失效时，就会出现自身免疫性疾病。开发预防或治愈自身免疫性疾病的治疗方法将需要对控制免疫反应的机制进行彻底和全面的了解。这个项目的重点是了解一种参与调节T细胞激活的新蛋白质的功能。